HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 86 filers reported holding HARPOON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,269,662 | -4.6% | 3,196,707 | 0.0% | 0.46% | -26.1% |
Q1 2023 | $2,378,350 | +2.5% | 3,196,707 | 0.0% | 0.62% | +2.7% |
Q4 2022 | $2,320,809 | -25.2% | 3,196,707 | 0.0% | 0.60% | -18.0% |
Q3 2022 | $3,101,000 | -49.2% | 3,196,707 | 0.0% | 0.73% | -56.7% |
Q2 2022 | $6,106,000 | -61.6% | 3,196,707 | 0.0% | 1.70% | -60.2% |
Q1 2022 | $15,888,000 | -34.2% | 3,196,707 | 0.0% | 4.26% | -3.1% |
Q4 2021 | $24,135,000 | -4.4% | 3,196,707 | 0.0% | 4.40% | +12.3% |
Q3 2021 | $25,254,000 | -43.0% | 3,196,707 | 0.0% | 3.92% | -46.2% |
Q2 2021 | $44,338,000 | -45.6% | 3,196,707 | -18.0% | 7.28% | -28.9% |
Q1 2021 | $81,555,000 | -37.0% | 3,898,422 | -50.0% | 10.25% | -8.4% |
Q4 2020 | $129,506,000 | +95.5% | 7,796,844 | +100.0% | 11.18% | -29.9% |
Q3 2020 | $66,234,000 | +2.3% | 3,898,422 | 0.0% | 15.96% | -7.3% |
Q2 2020 | $64,714,000 | +43.4% | 3,898,422 | 0.0% | 17.21% | -37.6% |
Q1 2020 | $45,144,000 | -21.7% | 3,898,422 | 0.0% | 27.58% | +35.0% |
Q4 2019 | $57,658,000 | – | 3,898,422 | – | 20.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |